Press Releases
DashGo launches new platform that enables music creators to manage their online presence from a central location
Los Angeles, CA, April 29, 2008 - DashGo is excited to announce the launch of their new service that makes it easy for "artists, labels, and content owners to syndicate content across digital music stores and social media sites from a single dashboard." By tracking performance of content across social media sites and digital music stores, DashGo enables content owners to react rapidly to demand and quickly scale distribution while maintaining a consistent brand.
Agile has worked with the DashGo team over the last several months to iteratively develop a site with a user experience and functionality finely tuned to the needs of artists, labels, content owners, and marketers. Making use of the latest web technologies, including Ruby on Rails and the application programming interfaces (APIs) of online social networks and digital music distributors, the dashgo.com site gives content owners the tools to manage their distributed online presence from a centralized location with an ease that has never been achievable before.
For more information on the site please contact DashGo or Agile Partners. We've had a great time working with their team and are excited to continue to help enhance and enrich the experience available at dashgo.com.
Dr. Silvia N. Bonaccorso, MD joins Agile's Board of Advisors
New York, NY, February 25, 2008 - Agile announced today that Dr. Silvia N. Bonaccorso, M.D. has joined Agile's Board of Advisors effective February 25, 2008.
Dr. Bonaccorso earned her Doctor of Medicine degree from the University of Buenos Aires Faculty of Medicine. Her post-graduate training and practice was in infectious diseases, internal medicine and nephrology. She also established and managed a renal hemodialysis unit in Buenos Aires.
During the early 1970's, Dr. Bonaccorso was a leading television anchorwoman in Argentina. In 1976, she was appointed Director of Professional Relations for Merck Sharp & Dohme Argentina (a fully-owned subsidiary of Merck & Co., Inc.) and held that position until 1979 when she returned to private medical practice.
Following eight years of medical practice, Dr. Bonaccorso rejoined Merck in 1987 at the company's global headquarters in New Jersey. She enjoyed a long and distinguished career before retiring in 2006 as Senior Vice President, Worldwide Marketing & Medical Services. Her broad range of responsibilities included the development and implementation of strategic marketing, medical and training programs, materials and services, as well as the delivery of clinical development, market research and outcomes research support for the company’s worldwide human health business.
Through Dr. Bonaccorso’s vision and leadership, several major milestones were achieved at Merck: global branding was established for all new products; Merck entered the Internet age under her direction; the company began using electronic data capture in clinical research; a global publications strategy was developed and implemented; and marketing and sales information systems were established between the company’s headquarters and subsidiaries around the world.
Dr. Bonaccorso was a member of the Editorial Board for the British Medical Journal from 2002 to 2006 and she is a member of the International Society of Nephrology.
She is a big fan of Formula One Racing (Ferrari, of course) and no Soccer World Cup has been held without her presence since 1978. Dr. Bonaccorso is an avid reader, and loves listening to music and dancing.
Brock Reeve, Executive Director, Harvard Stem Cell Institute joins Agile's Board of Advisors
New York, NY, February 25, 2008 - Agile announced today that Brock Reeve MPhil, MBA has joined Agile's Board of Advisors effective February 25, 2008.
A graduate of Yale and the Harvard Business School, Brock is Executive Director of the Harvard Stem Cell Institute. In partnership with the Faculty Directors, he has overall responsibility for the operations and strategy of the institute whose mission is to use stem cells, both as tools and as therapies, to understand and treat the root causes of leading degenerative diseases. HSCI is comprised of the schools of Harvard University and all its affiliated hospitals and research institutions. The institute currently has 60 principal faculty and 70 affiliated faculty.
Brock has extensive experience in both management consulting and operations for technology-based companies, with a focus on life sciences. His business career started with the Boston Consulting Group. Prior to Harvard, Brock was COO and Managing Director of Life Science Insights, an IDC company, a consulting and market research firm specializing in information technology in life sciences. LSI worked with biopharmaceutical companies helping them understand how best to leverage information technology at all stages of the business value chain and with life science software and hardware companies helping them understand their market and associated opportunities. Prior to LSI, Brock was an Associate Partner in the Pharmaceutical and Life Sciences practice in IBM’s Business Consulting Services group, working with biotech and pharmaceutical clients on issues ranging from R&D portfolios to operations strategies. Brock also has had hands-on operational responsibility in product management and marketing roles in software start-ups as well as additional experience in IT and the healthcare/life science market as the Healthcare Practice Director at Viant Corp. and a Principal at SRI Consulting, where his clients included some of the leading pharmaceutical, biotechnology and medical device companies.